How is your business helping to solve the health, social, or economic challenges created by COVID19?
In short, we are an on-ramp for rapid commercialization and distribution of new but evidence-based Covid19 innovations. Maternova already has relationships with Ministries of Health, distributors and customers around the world who are addressing infectious disease and epidemics. We also have supply chain and distribution networks in place. The first product we are accelerating is a Covid19 immunoassay with high sensitivity and specificity. We have the capacity to bring portable xray machines, pneumonia diagnostics and pharmaceuticals onto our platform rapdily and to credibly market these products globally because of our reputation in the global health space (maternova.net).
Does your business contribute most to recovery, response, or resilience?
Response - we're responding directly to issues caused or exacerbated by the COVID-19 outbreak.
What is the stage of your product development?
I have a market ready product/service. I have sold to customers.
What strengths does your team bring? Include skills and personal experience with the problem.
Maternova is a licensing and distribution platform for global health technologies, built on a strong and trusted brand. Our management team is experienced and between our Scientific and Business advisory boards we have a combination of public health, medical and international business acumen. We have a rigorous method for vetting technologies and we have credibility with high-level customers around the world.
What countries do you operate in?
We drop ship from Canada, India, South Africa and India to countries ranging from Brazil, Colombia, Mexico and Peru to Kenya, South Africa and India. Our entire product portfolio is designed for global health response and humanitarian response. We have trusted partners and a strong reputation at all points of the supply chain.
Is your company headquartered in a US "Opportunity Zone"?
Yes
